Switch to:
More From Other Websites
The FDA Committee Vote That Could Sink Vertex May 28 2015
Vertex CEO’s $45.8 Million Pay Last Year ‘Excessive,’ ISS Says May 26 2015
5 Drugs That Could Be Summer Blockbusters May 26 2015
10 S&P 500 Companies to Have the Most Revenue Growth in 2015 May 20 2015
How to play weak Q2 earnings season: Analysts May 18 2015
New England Journal of Medicine Publishes Data from Two Phase 3 Studies of ORKAMBITM... May 17 2015
What You Need To Know In Biotech: An ASCO Disappointment, Big Money In Brains And A New CF Drug May 16 2015
Vertex Could Give Investors Vertigo May 13 2015
Vertex to Present at the UBS Healthcare Conference on May 19 May 13 2015
Vertex to Present at the UBS Healthcare Conference on May 19 May 13 2015
Gilead: No Big Deals May 13 2015
Vertex Pharmaceuticals (VRTX) Stock Climbs Following FDA Advisory Panel Aprroval May 13 2015
Analyst: Patients were key to Vertex panel recommendation May 13 2015
Vertex Pharmaceuticals' Orkambi Wins FDA Panel Backing - Analyst Blog May 13 2015
Vertex: 'We Remain Confident in Approval,' JPMorgan Says May 13 2015
Vertex Shares Rally As FDA Panel Backs Orkambi; HC Wainwright Analyst Offers Thoughts May 13 2015
Early movers: DAL, PLL, HUM, VZ, KMB, FB & more May 13 2015
FDA Panel Backs Vertex Cystic-Fibrosis Drug Orkambi May 12 2015
Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More May 12 2015
IBD Market Wrap - 05/12/15 May 12 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK